Pulmonary hypertension in women

Area of Science:

• Cardiovascular Science
• Endocrinology
• Pulmonary Medicine

Background:

• Pulmonary arterial hypertension (PAH) predominantly affects females.
• Estrogens are generally considered protective in the pulmonary vasculature.
• The underlying mechanisms for female predominance in PAH remain incompletely understood.

Purpose of the Study:

• To explore the role of sex hormones, particularly estrogens, in the development of pulmonary arterial hypertension (PAH).
• To investigate how altered estrogen levels, signaling, and metabolism contribute to gender differences in PAH.
• To examine the impact of sex hormones on the right ventricle in PAH.

Main Methods:

• Review of basic science data on estrogen effects in the pulmonary vasculature.
• Analysis of recent human and rodent data concerning estrogen metabolism and signaling in PAH.
• Consideration of studies on sex hormone effects on the right ventricle.

Main Results:

• Estrogen's acute and chronic effects on the pulmonary vasculature appear beneficial, contrasting with female predilection in PAH.
• Evidence suggests that altered estrogen levels, differential signaling, and metabolism in PAH contribute to gender disparities.
• Sex hormone influences on the right ventricle are crucial for understanding PAH gender differences.

Conclusions:

• Sex hormones, especially estrogens, play a complex role in PAH pathogenesis, contributing to its female predominance.
• Understanding these sex-specific mechanisms is vital for developing targeted PAH therapies.
• Further research into sex hormone effects on the pulmonary vasculature and right ventricle is warranted.